UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?

Frontiers in oncology, 2019-05, Vol.9, p.402-402

2019

Volltextzugriff (PDF)

Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients

Blood, 2012-01, Vol.119 (2), p.488-493

2012

Volltextzugriff (PDF)

Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

Nature communications, 2023-10, Vol.14 (1), p.6761-21, Article 6761

2023

Volltextzugriff (PDF)

Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia

Haematologica (Roma), 2019-07, Vol.104 (7), p.1451-1459

2019

Volltextzugriff (PDF)

Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia

Blood, 2017-03, Vol.129 (10), p.1333-1342

2017

Volltextzugriff (PDF)

Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia

Haematologica (Roma), 2017-09, Vol.102 (9), p.1567-1577

2017

Volltextzugriff (PDF)

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up

Haematologica (Roma), 2017-08, Vol.102 (8), p.1424-1431

2017

Volltextzugriff (PDF)

Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice

Cancers, 2022-06, Vol.14 (12), p.2905

2022

Volltextzugriff (PDF)

Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia

Journal of clinical oncology, 2013-11, Vol.31 (31), p.3898-3905

2013

Volltextzugriff (PDF)

RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples

Cancers, 2019-09, Vol.11 (9), p.1309

2019

Volltextzugriff (PDF)

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Journal of hematology and oncology, 2019-04, Vol.12 (1), p.44-44, Article 44

2019

Volltextzugriff (PDF)

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis

Haematologica (Roma), 2017-07, Vol.102 (7), p.1281-1290

2017

Volltextzugriff (PDF)

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma

Blood advances, 2018-01, Vol.2 (1), p.1-9

2018

Volltextzugriff (PDF)

DNA Damage-Induced Accumulation of Centrosomal Chk1 Contributes to its Checkpoint Function

Cell cycle (Georgetown, Tex.), 2007-10, Vol.6 (20), p.2541-2548

2007

Volltextzugriff (PDF)

Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis

Haematologica (Roma), 2008-03, Vol.93 (3), p.459-462

2008

Volltextzugriff (PDF)

Diagnosis and management of metastatic neoplasms with unknown primary

Seminars in diagnostic pathology, 2018-05, Vol.35 (3), p.199-206

2018

Volltextzugriff (PDF)

Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens

Journal of clinical oncology, 2015-04, Vol.33 (12), p.1371-1378

2015

Volltextzugriff (PDF)

AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis

Blood, 2017-08, Vol.130 (5), p.632-642

2017

Volltextzugriff (PDF)

Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary

Clinical chemistry (Baltimore, Md.), 2024-01, Vol.70 (1), p.297-306

2024

Volltextzugriff (PDF)

Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primary

European journal of cancer (1990), 2021-11, Vol.157, p.179-189

2021

Volltextzugriff (PDF)

Management of a Pregnant ALK-Positive Lung Cancer Patient With Alectinib-Induced Pneumonitis and Bilateral Globus Pallidus Necrosis Postpartum

Clinical lung cancer, 2024-01, Vol.25 (1), p.72-76

2024

Volltextzugriff (PDF)

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience

The oncologist (Dayton, Ohio), 2021-05, Vol.26 (5), p.e769-e779

2021

Volltextzugriff (PDF)

Treatment of AL amyloidosis with bendamustine: a study of 122 patients

Blood, 2018-11, Vol.132 (18), p.1988-1991

2018

Volltextzugriff (PDF)

Cancer of unknown primary-The new ESMO guidelines

Radiologie (Heidelberg, Germany), 2023-05, Vol.63 (5), p.329-335

2023

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(48)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?

Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients

Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia

Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia

Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up

Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice

Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia

RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma

DNA Damage-Induced Accumulation of Centrosomal Chk1 Contributes to its Checkpoint Function

Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis

Diagnosis and management of metastatic neoplasms with unknown primary

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens

AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis

Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary

Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primary

Management of a Pregnant ALK-Positive Lung Cancer Patient With Alectinib-Induced Pneumonitis and Bilateral Globus Pallidus Necrosis Postpartum

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience

Treatment of AL amyloidosis with bendamustine: a study of 122 patients

Cancer of unknown primary-The new ESMO guidelines

Aktive Filter

Suchergebnisse filtern